Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial

Harrison, TW; Chanez, P; Menzella, F; Canonica, GW; Louis, R; Cosio, BG; Lugogo, NL; Mohan, A; Burden, A; McDermott, L; Gil, EG; Zangrilli, JG

Harrison, TW (corresponding author), Univ Nottingham, Nottingham Natl Inst Hlth Res Biomed Res Ctr, Resp Res Unit, Nottingham City Hosp, Nottingham NG5 1PB, England.

LANCET RESPIRATORY MEDICINE, 2021; 9 (3): 260

Abstract

Background ANDHI was done to assess the efficacy of benralizumab, including onset of effect and impact on health-related quality of life (HRQOL), exac......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索